Inventors with similar research interests:
Company Filing History:
72 out of 4,945 
1 out of 832,843 Years Active: 1976-1994
Areas of Expertise:
Title: Innovations and Contributions of Armin Walser in the Field of Pharmaceuticals
Introduction
Armin Walser is a prominent inventor based in West Caldwell, NJ, with an impressive portfolio of 73 patents. His work primarily focuses on the development of pharmaceutical compounds aimed at treating anxiety, panic disorders, and various inflammatory diseases. His innovative contributions have significantly impacted the pharmaceutical industry and continue to pave the way for new therapeutic options.
Latest Patents
Two of Walser's latest inventions underscore his commitment to addressing critical health issues. The first patent concerns benzodiazepines and compositions for treating anxiety and panic. It details imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide compounds, which exhibit anti-anxiety and anti-epileptic activity. The second patent focuses on chromanes and their pharmaceutical compositions. It describes racemic compounds that serve as inhibitors of 5-lipoxygenase, providing therapeutic potential for diseases linked to oxidative stress, including arthritis, allergies, asthma, and psoriasis.
Career Highlights
Throughout his career, Walser has been affiliated with reputable organizations such as Hoffmann-La Roche Inc. His extensive experience in the pharmaceutical field has positioned him as a leading figure in drug innovation, contributing to the development of numerous therapeutic agents that improve patient outcomes.
Collaborations
Walser has collaborated with notable professionals in the industry, including Rodney I. Fryer and Eugene J. Trybulski. These collaborations have fostered the exchange of ideas and expertise, allowing for advancements in research and development within the pharmaceutical sector.
Conclusion
Armin Walser's remarkable achievements and innovations in pharmaceuticals underline his dedication to developing effective treatments for pressing health challenges. With a robust patent portfolio and significant contributions to drug development, he remains an influential figure in the field, continually striving to improve the quality of life for patients through innovative solutions.